Search Results - "Degenhardt, K"

Maternal hyperoxygenation improves left heart filling in fetuses with atrial septal aneurysm causing impediment to left ventricular inflow by Channing, A., Szwast, A., Natarajan, S., Degenhardt, K., Tian, Z., Rychik, J.

“…Linked Comment: Ultrasound Obstet Gynecol 2015; 45: 630–630 ABSTRACT Objectives Aneurysm of the atrial septum (AAS) with excessive excursion of septum primum…”
Get full text

Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells by Martino, J J, Wall, B A, Mastrantoni, E, Wilimczyk, B J, La Cava, S N, Degenhardt, K, White, E, Chen, S

“…Non-neuronal expression of components of the glutamatergic system has been increasingly observed, and our laboratory previously had demonstrated the…”
Get full text

Bfl-1 A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist by Simmons, M J, Fan, G, Zong, W-X, Degenhardt, K, White, E, Gélinas, C

“…The prosurvival Bcl-2-family member Bfl-1/A1 is a transcriptional target of nuclear factor-κB (NF-κB) that is overexpressed in many human tumors and is a means…”
Get full text

Visualization and functional characterization of the developing murine cardiac conduction system by Rentschler, S, Vaidya, D M, Tamaddon, H, Degenhardt, K, Sassoon, D, Morley, G E, Jalife, J, Fishman, G I

“…The cardiac conduction system is a complex network of cells that together orchestrate the rhythmic and coordinated depolarization of the heart. The molecular…”
Get full text

Early Weight Gain as a Predictor of Substantial Weight Gain With Olanzapine/Fluoxetine Combination: An Analysis of 2 Adult Studies in Treatment-Resistant Depression by DEGENHARDT, Elisabeth K, JAMAL, Hassan H, TORMEY, Susan, CASE, Michael

“…Weight gain during olanzapine/fluoxetine combination (OFC) therapy is very common. We examined early (at 2 weeks) weight gain as a predictor of later (at 26…”
Get full text

Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis by Sassoon, David A, Miller, Cary, Degenhardt, Karl

Get full text

Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2 by Corbalan-Garcia, S, Yang, S-S, Degenhardt, K R, Bar-Sagi, D

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Number Needed to Treat or Harm Analyses of Olanzapine for Maintenance Treatment of Bipolar Disorder by TOHEN, Mauricio, SNIADECKI, Jennifer, SUTTON, Virginia K, DEGENHARDT, Elisabeth K, KARAGIANIS, Jamie L, SAGMAN, Doron, JACOBSON, Jennie G

“…The number-needed-to-treat (NNT) or the number-needed-to-harm (NNH) analysis was performed on olanzapine and comparators for all known controlled clinical…”
Get full text

Relationship between African–American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of America by Degenhardt, Elisabeth K, Tamayo, Jorge M, Jamal, Hassan H, Gatz, Jennifer, Tohen, Mauricio, Durell, Todd M

“…The aim of this study was to explore the role of ethnic origin in the treatment of acute bipolar mania. Treatment outcomes were studied in a post-hoc analysis…”
Get full text

Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia by Degenhardt, Elisabeth K., R.N., M.S.N, Witte, Michael M., Ph.D, Case, Michael G., M.S, Yu, Peng, Ph.D, Henley, David B., M.D, Hochstetler, Helen M., Pharm.D, D’Souza, Deborah N., Ph.D., M.B.A, Trzepacz, Paula T., M.D

“…Background Clinical diagnosis of Alzheimer disease (AD) is challenging, with a 70.9%–87.3% sensitivity and 44.3%–70.8% specificity, compared with autopsy…”
Get full text

Symptoms predicting remission after divalproex augmentation with olanzapine in partially nonresponsive patients experiencing mixed bipolar I episode: a post-hoc analysis of a randomized controlled study by Houston, John P, Gatz, Jennifer L, Degenhardt, Elisabeth K, Jamal, Hassan H

“…Rating scale items in a 6-week clinical trial of olanzapine versus placebo augmentation in patients with mixed bipolar disorder partially nonresponsive to ≥14…”
Get full text

Predictors of relapse or recurrence in bipolar I disorder by Degenhardt, Elisabeth K, Gatz, Jennifer L, Jacob, Jayanthi, Tohen, Mauricio

“…Abstract Objectives Bipolar disorder represents a major public health concern and, despite treatment, is characterized by recurring episodes of mania,…”
Get full text

Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease by Trzepacz, Paula T, Hochstetler, Helen, Yu, Peng, Castelluccio, Peter, Witte, Michael M, Dell'Agnello, Grazia, Degenhardt, Elisabeth K

“…To assess how hippocampal volume (HV) from volumetric magnetic resonance imaging (vMRI) is related to the amyloid status at different stages of Alzheimer's…”
Get more information

Chronological age of patients with Turner syndrome at diagnosis by Simm, D, Degenhardt, K, Gerdemann, C, Völkl, T M K, Rauch, A, Dörr, H G

“…Phenotypically, Turner syndrome (TS) is characterized by great variability, with short stature being the most constant incidence. Growth hormone therapy can…”
Get more information

Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study by HOUSTON, John P, TOHEN, Mauricio, DEGENHARDT, Elisabeth K, JAMAL, Hassan H, LIU, Lin L. L, KETTER, Terence A

“…This 6-week, randomized, double-blind, placebo-controlled trial used simultaneous depression and mania criteria to compare a single mood stabilizer,…”
Get full text

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers by Hake, Ann, Trzepacz, Paula T, Wang, Shufang, Yu, Peng, Case, Michael, Hochstetler, Helen, Witte, Michael M, Degenhardt, Elisabeth K, Dean, Robert A

“…Abstract Background We evaluated the relationship between florbetapir-F18 positron emission tomography (FBP PET) and cerebrospinal fluid (CSF) biomarkers…”
Get full text

Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia by Deberdt, Walter G, Dysken, Maurice W, Rappaport, Stephen A, Feldman, Peter D, Young, Carrie A, Hay, Donald P, Lehman, Deborah L, Dossenbach, Martin, Degenhardt, Elisabeth K, Breier, Alan

“…The authors compared efficacy of olanzapine versus placebo and risperidone as measured by the Neuropsychiatric Inventory and Clinical Global…”
Get more information

Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes by Houston, John P, Ketter, Terence A, Case, Michael, Bowden, Charles, Degenhardt, Elisabeth K, Jamal, Hassan H, Tohen, Mauricio

“…Abstract Potential predictors of remission in mixed bipolar I disorder were identified using early Clinical Global Impression-Severity (CGI-S) improvement…”
Get full text

Insulin-induced dissociation of Sos from Grb2 does not contribute to the down regulation of Ras activation by Corbalan-Garcia, S, Degenhardt, K R, Bar-Sagi, D

“…Activation of Ras by a number of receptor tyrosine kinases is mediated by the guanine nucleotide exchange factor Sos. This activation is thought to occur as a…”
Get more information

DOES HIPPOCAMPAL VOLUME PREDICT POSITIVE AMYLOID STATUS ON FLORBETAPIR-PET IN HEALTHY CONTROLS AND PRODROMAL STAGES OF ALZHEIMER'S DISEASE? by Trzepacz, Paula T, Peng, Yu, Castelluccio, Peter, Hochstetler, Helen M, Joshi, Abhinay, Dell'Agnello, Grazia, Degenhardt, Elisabeth K, Selzler, Katherine J, Witte, Michael M, Devous, Michael D, Schwarz, Adam J

Get full text